Bioventus Inc.
BVS
$8.61
$0.101.12%
NASDAQ
| 03/28/2026 | 12/31/2025 | 09/27/2025 | 06/28/2025 | 03/29/2025 | |
|---|---|---|---|---|---|
| Net Income | 184.09% | 162.93% | 118.14% | 98.34% | -54.17% |
| Total Depreciation and Amortization | 7.41% | 11.30% | -9.28% | -11.88% | -13.19% |
| Total Amortization of Deferred Charges | -34.89% | -34.89% | -16.67% | -16.67% | -16.67% |
| Total Other Non-Cash Items | -31.50% | -34.10% | -11.00% | -9.37% | 141.45% |
| Change in Net Operating Assets | 125.46% | -17.49% | -187.84% | -41.95% | -8.52% |
| Cash from Operations | 304.17% | 92.48% | 87.71% | 223.15% | 271.86% |
| Capital Expenditure | -49.90% | -154.67% | -219.10% | 22.57% | 62.35% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -102.78% | -102.78% | 10,907.21% | 10,907.21% | -28.83% |
| Other Investing Activities | -- | -- | 100.00% | 100.00% | 100.00% |
| Cash from Investing | -112.95% | -114.14% | 1,337.64% | 689.77% | -22.55% |
| Total Debt Issued | 312.71% | -- | -- | 0.00% | 0.00% |
| Total Debt Repaid | -15.48% | 9.28% | -549.88% | -218.03% | 12.50% |
| Issuance of Common Stock | -15.36% | -15.07% | 78.09% | 132.89% | 177.27% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -1,379.29% | -3,498.13% | -4,208.25% | -748.81% | -37.95% |
| Cash from Financing | -74.59% | -13.85% | -552.08% | -1,351.68% | 15.24% |
| Foreign Exchange rate Adjustments | 57.94% | 114.49% | -1,314.73% | 6.76% | -321.81% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 650.15% | 109.09% | -105.60% | -64.84% | 89.19% |